A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

Clinical trial NCT02004704 · COMPLETED

Trial details

NCT number: NCT02004704
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sphingomyelin Lipidosis

Start date: 2013-12-04
Primary completion: 2023-09-06
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.